HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Hepatology - United States
doi 10.1002/hep.30127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-Positive Intrahepatic Cholangiocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2018English

Antitumor Effect of FGFR Inhibitors on a Novel Cholangiocarcinoma Patient Derived Xenograft Mouse Model Endogenously Expressing an FGFR2-CCDC6 Fusion Protein

Cancer Letters
Cancer ResearchOncology
2016English

Iron-Dependent Oxidation, Ubiquitination, and Degradation of Iron Regulatory Protein 2: Implications for Degradation of Oxidized Proteins

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2015English

Inhibition of L-Type Amino Acid Transporter 1 Activity as a New Therapeutic Target for Cholangiocarcinoma Treatment

Tumor Biology
MedicineCancer Research
2017English

Novobiocin: Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90

English

Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From Clostridium Botulinum C2 Toxin

Frontiers in Pharmacology
Pharmacology
2018English

Erratum: Targeting Proteins for Degradation

Nature Chemical Biology
Cell BiologyMolecular Biology
2009English

Membrane Fusion Triggers Rapid Degradation of Two Gamete-Specific, Fusion-Essential Proteins in a Membrane Block to Polygamy in Chlamydomonas

Development (Cambridge)
Developmental BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy